See more : RailTel Corporation of India Limited (RAILTEL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Danimer Scientific, Inc. (DNMR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danimer Scientific, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Beardsell Limited (BEARDSELL.NS) Income Statement Analysis – Financial Results
- Aries I Acquisition Corporation (RAMMW) Income Statement Analysis – Financial Results
- FIG (7708.TWO) Income Statement Analysis – Financial Results
- Lianhua Supermarket Holdings Co., Ltd. (LHUAF) Income Statement Analysis – Financial Results
- Beard Co. (The) (BRCOQ) Income Statement Analysis – Financial Results
Danimer Scientific, Inc. (DNMR)
About Danimer Scientific, Inc.
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 46.68M | 53.22M | 58.75M | 47.33M | 32.34M | 30.45M |
Cost of Revenue | 73.64M | 63.63M | 57.87M | 35.88M | 21.24M | 19.21M |
Gross Profit | -26.96M | -10.41M | 884.00K | 11.46M | 11.11M | 11.25M |
Gross Profit Ratio | -57.75% | -19.57% | 1.50% | 24.21% | 34.34% | 36.92% |
Research & Development | 29.24M | 31.94M | 20.27M | 7.85M | 5.48M | 5.14M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.26M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K |
SG&A | 68.98M | 81.59M | 80.00M | 19.34M | 16.03M | 7.36M |
Other Expenses | 434.00K | 723.00K | -44.00K | -31.00K | 277.00K | 0.00 |
Operating Expenses | 98.66M | 113.53M | 100.27M | 27.19M | 21.51M | 8.11M |
Cost & Expenses | 172.30M | 177.16M | 158.14M | 63.07M | 42.75M | 27.32M |
Interest Income | 0.00 | 1.72M | 763.00K | 347.00K | 340.00K | 2.88M |
Interest Expense | 0.00 | 112.25M | 763.00K | 2.43M | 3.48M | 0.00 |
Depreciation & Amortization | 29.06M | 20.09M | 11.67M | 4.61M | 3.51M | 3.54M |
EBITDA | -96.46M | -103.49M | -87.72M | -10.30M | -6.90M | 2.35M |
EBITDA Ratio | -206.61% | -90.63% | -151.15% | -21.76% | -12.87% | 7.70% |
Operating Income | -125.62M | -187.43M | -99.39M | -15.74M | -10.40M | -1.19M |
Operating Income Ratio | -269.08% | -352.20% | -169.18% | -33.25% | -32.16% | -3.91% |
Total Other Income/Expenses | -29.54M | 6.87M | 26.13M | 6.88M | -5.03M | -2.91M |
Income Before Tax | -155.15M | -180.57M | -73.34M | -12.57M | -15.43M | 259.00K |
Income Before Tax Ratio | -332.35% | -339.30% | -124.84% | -26.56% | -47.70% | 0.85% |
Income Tax Expense | 319.00K | -810.00K | -13.23M | 2.40M | 4.09M | 51.00K |
Net Income | -155.47M | -179.76M | -60.11M | -14.97M | -19.51M | 208.00K |
Net Income Ratio | -333.03% | -337.78% | -102.31% | -31.62% | -60.33% | 0.68% |
EPS | -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
EPS Diluted | -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
Weighted Avg Shares Out | 102.00M | 101.10M | 93.08M | 84.54M | 25.37M | 2.97M |
Weighted Avg Shares Out (Dil) | 102.00M | 101.10M | 93.08M | 84.54M | 25.37M | 2.96M |
Danimer Scientific Announces Release Date for First Quarter 2024 Results
Danimer Scientific Announces $20 Million Asset-Based Revolving Credit Facility
Down -41.74% in 4 Weeks, Here's Why Danimer Scientific (DNMR) Looks Ripe for a Turnaround
Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript
Danimer Scientific, Inc. (DNMR) Reports Q4 Loss, Tops Revenue Estimates
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
Danimer Scientific Announces Closing of $15 Million Registered Direct Offering
Danimer Scientific Announces $15 Million Registered Direct Offering
Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2023 Results
Danimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant Capacity
Source: https://incomestatements.info
Category: Stock Reports